Solution
For pharmacovigilance, drug-safety and medical-affairs teams: PubMed, Embase and local journals screened at scale, with Day 0 criteria flagged on intake and every disposition logged for inspection.
The problem
Weekly screening returns thousands of hits, most of them false positives, and qualified reviewers spend their hours discarding irrelevant articles instead of analyzing the ones that matter.
One publication appears in PubMed, Embase, a local journal index and a conference feed — and gets reviewed four times unless someone catches it.
Every day an ICSR candidate sits in a triage queue is a day against the regulatory clock, and the clock starts at first awareness.
The product, not a promise
How it works
Pulls abstracts and full texts from PubMed, Embase, local journals and conference sources on your search schedule.
Matches the same article across databases so reviewers see it once, not four times.
Scores each article for relevance and separates safety signals from efficacy data and noise.
Pulls Patient-Drug-Event relationships and flags Day 0 criteria for ICSR triage.
Routes ranked candidates to reviewers; every disposition is logged for inspection.
Who it's for
Safety reviewer
PV operations lead
QA & inspection readiness
Literature surveillance breaks at volume. Teams screen thousands of abstracts a week across PubMed, Embase and local journals, and keyword search buries them in false positives. Reviewers spend their hours discarding irrelevant articles instead of analyzing the ones that matter — and every day of triage backlog is a day an adverse event goes unreported.
Botminds agents read the literature the way a trained reviewer does. They ingest from subscription databases, conference abstracts and open-web sources, deduplicate records that appear in more than one database, and classify each article by what it actually contains: a valid safety signal, efficacy data, or noise. Entity recognition and relevance scoring rank the queue so high-severity candidates surface first. The agent extracts Patient-Drug-Event relationships and highlights Day 0 criteria, so ICSR candidates move to triage the day they appear — before a backlog forms, and well before one clears.
The same pipeline extends without new headcount: add a therapeutic area, a local journal or a new source, and the agents cover it on the next cycle.
Pharmacovigilance is a document-to-decision operation, and regulators audit the decisions. The platform keeps the complete trail: which search strings ran, which articles were retrieved, how each was classified, who reviewed it and what they decided. Every extracted relationship is cited to the passage it came from, so a reviewer — or an inspector — can check the evidence in one click. Nothing is auto-dispositioned into silence: reviewers approve every safety-relevant call, and the system records that they did.
Safety, clinical development and medical writing teams work from one shared repository of validated findings instead of parallel spreadsheets — the same article, the same disposition, the same evidence, everywhere it is needed.
Objections, answered
The machine screens; humans decide. Every classification is checkable — extracted Patient-Drug-Event relationships are cited to the passage they came from — and every safety-relevant disposition requires reviewer approval, which is logged. Nothing is silently discarded.
Yes. The agents run your search strings on your schedule against your sources, and the workflow follows your SOP: your relevance criteria, your triage rules, your reviewer roles. The platform executes the strategy; it doesn't replace it.
The complete trail is kept by design: which searches ran, which articles were retrieved, how each was classified, who reviewed it and what they decided. An inspector can walk from any disposition back to the source passage in one click.
Weeks. The solution is pre-built; configuration is your product list, search strategies and sources. Extending coverage later — a new therapeutic area, a new local journal — is a configuration change, picked up on the next screening cycle.
Watch it deduplicated, classified and ranked with Day 0 candidates flagged — live, on your search strategy.
Request a demo